v3.25.3
Condensed Consolidated Statements of Operations (Loss) (Unaudited) - EUR (€)
€ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue € 49 € 0 € 101 € 0
Cost of sales 18 0 57 0
Gross margin 31 0 44 0
Operating Expenses and Costs        
Selling and distribution expenses 186 205 662 448
General and administrative expenses 1,231 753 3,512 3,627
Research and development 435 519 1,402 1,076
Gain on reconsolidation 0 0 0 (63,491)
Other Operating (income)/loss (250) 4 (381) (66)
Total Operating Expenses and Costs 1,602 1,481 5,195 (58,406)
(Loss)/Income from Operations (1,571) (1,481) (5,151) 58,406
Other Income (Expenses)        
(Loss) / income from changes in fair value of convertible note payable carried at fair value (35) (8,809) 11,108 13,100
Gain / (loss) on foreign currency transactions 215 783 675 (1,575)
Total Other (Expense) / Income (180) (8,026) 11,783 11,525
Net (loss) / income € (1,391) € (9,507) € 6,632 € 69,931
Basic (in EUR per Share) € (0.95) € (6.56) € 4.56 € 48.26
Diluted (in EUR per Share) € (0.95) € (6.56) € 0.72 € 3.58
Basic (in shares) 1,463,101 1,449,868 1,454,361 1,449,060
Diluted (in shares) 1,463,101 1,449,868 9,206,350 19,542,240